VALANX Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, specifically Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents, resulting in antibody-drug conjugates designed for cancer treatment. Additionally, Norl is applicable for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biosensors and biocatalysts. VALANX Biotech also provides on-demand bioanalytics and mass spectrometry services, further enhancing its offerings in the field of protein-drug conjugate development.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
We develop a transparent window film to make glass visible to birds.
VALANX Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, specifically Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents, resulting in antibody-drug conjugates designed for cancer treatment. Additionally, Norl is applicable for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biosensors and biocatalysts. VALANX Biotech also provides on-demand bioanalytics and mass spectrometry services, further enhancing its offerings in the field of protein-drug conjugate development.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
VALANX Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, specifically Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents, resulting in antibody-drug conjugates designed for cancer treatment. Additionally, Norl is applicable for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biosensors and biocatalysts. VALANX Biotech also provides on-demand bioanalytics and mass spectrometry services, further enhancing its offerings in the field of protein-drug conjugate development.
We develop a transparent window film to make glass visible to birds.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Robo Wunderkind is a startup based in Vienna, Austria. We build tools that enhance the way kids play, learn, and create with tech in school and at home. Our award-winning robotics kits empower kids to learn to code through the joy of play. Based in Vienna as well as San Francisco, California. In the summer of 2014, the team was part of the first worldwide hardware accelerator HAX. The progress made there was incorporated into Robo, earning them the "Robot of the Year" Award from Festo and the Austrian Startup of the Year Award in 2015.
VALANX Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, specifically Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents, resulting in antibody-drug conjugates designed for cancer treatment. Additionally, Norl is applicable for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biosensors and biocatalysts. VALANX Biotech also provides on-demand bioanalytics and mass spectrometry services, further enhancing its offerings in the field of protein-drug conjugate development.
VALANX Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, specifically Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents, resulting in antibody-drug conjugates designed for cancer treatment. Additionally, Norl is applicable for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biosensors and biocatalysts. VALANX Biotech also provides on-demand bioanalytics and mass spectrometry services, further enhancing its offerings in the field of protein-drug conjugate development.
B2Holding ASA provides debt solutions for banks and institutional vendors. The company’s portfolio of business consists of purchase, management, and collection of unsecured and secured non-performing loans. It services include debt purchase and collection, credit information third party debt collection, and consumer lending, as well as telemarketing and fraud prevention services. It principally operates in Norway, Sweden, Denmark, Finland, Estonia, Latvia, Lithuania, Poland, Croatia, Slovenia, Serbia, Montenegro, Bosnia-Herzegovina, Austria, the Czech Republic, Hungary, Spain, Portugal, Italy, France, Bulgaria, Romania, Greece, and Cyprus. B2Holding SAS was founded in 2011 and is headquartered in Oslo, Norway.
Ageria Ltd. is a biotechnology company focused on developing yogurt enriched with health-promoting compounds, specifically targeting anti-aging benefits. Incorporated in 2015 and based in Vienna, Austria, Ageria utilizes a longevity compound known as Spermidine in its yogurt production. The company employs naturally engineered yogurt bacteria to enhance the health benefits of its products. With a commitment to advancing human longevity and well-being, Ageria aims to provide consumers with yogurt that supports a longer and healthier life.
Ageria Ltd. is a biotechnology company focused on developing yogurt enriched with health-promoting compounds, specifically targeting anti-aging benefits. Incorporated in 2015 and based in Vienna, Austria, Ageria utilizes a longevity compound known as Spermidine in its yogurt production. The company employs naturally engineered yogurt bacteria to enhance the health benefits of its products. With a commitment to advancing human longevity and well-being, Ageria aims to provide consumers with yogurt that supports a longer and healthier life.
Saphium Biotechnology GmbH produces PHAbulous Philaments that are bio-based plastics with the help of microbes. Its products are used for 3D printing, food packaging material, and other applications. The company was incorporated in 2015 and is based in Kapfenstein, Austria.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Robo Wunderkind is a startup based in Vienna, Austria. We build tools that enhance the way kids play, learn, and create with tech in school and at home. Our award-winning robotics kits empower kids to learn to code through the joy of play. Based in Vienna as well as San Francisco, California. In the summer of 2014, the team was part of the first worldwide hardware accelerator HAX. The progress made there was incorporated into Robo, earning them the "Robot of the Year" Award from Festo and the Austrian Startup of the Year Award in 2015.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.